# Blau Farmacêutica (BLAU3)

> Health Technology · BR · Reports in BRL

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BLAU3/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | R$ 921.57M | R$ 91.83M | R$ -198.83M | R$ 853.09M | R$ 2.32B |
| 2025 | R$ 1.78B | R$ 309.95M | R$ 142.16M | R$ 599.13M | R$ 2.26B |
| 2024 | R$ 1.91B | R$ 232.51M | R$ 209.60M | R$ 558.95M | R$ 2.15B |
| 2023 | R$ 1.57B | R$ 282.51M | R$ -155.53M | R$ 608.54M | R$ 2.00B |
| 2022 | R$ 1.68B | R$ 430.51M | R$ 364.08M | R$ 311.71M | R$ 1.82B |
| 2021 | R$ 1.73B | R$ 409.16M | R$ -905.01M | R$ 374.52M | R$ 1.63B |
| 2020 | R$ 1.64B | R$ 353.64M | R$ 7.97M | R$ 690.01M | R$ 221.34M |
| 2019 | R$ 1.42B | R$ 291.01M | R$ 108.51M | R$ 278.92M | R$ 265.76M |
| 2018 | R$ 1.19B | R$ 186.85M | R$ -107.20M | R$ 225.13M | R$ 223.33M |
| 2017 | R$ 971.45M | R$ 162.20M | R$ 142.03M | R$ 103.92M | R$ 138.34M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.37 |
| Debt ex Lease / Eq | 0.35 |
| Liabilities / Eq | 0.74 |
| Current Ratio | 3.23 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 2.70 |

## Other views

- [Metrics](https://sponda.capital/en/BLAU3.md)
- [Charts](https://sponda.capital/en/BLAU3/charts.md)
- [Compare](https://sponda.capital/en/BLAU3/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.